Information

  • Home
  • Call for Paper

Call For Papers

The ICAIBDD bridges the gap between academia and industry by promoting research with practical applications. It provides a platform for professionals and researchers to share insights that drive real-world impact.

The conference focuses on Artificial Intelligence,Data Science,Bioinformatics, encouraging applied research, case studies, and industry-driven innovations.

Authors are invited to submit papers addressing, but not limited to, the following areas:

  • AI-driven drug discovery methodologies
  • Bioinformatics in drug target identification
  • Machine learning for drug repurposing
  • Predictive modeling in drug discovery
  • Data mining for pharmacogenomics insights
  • AI applications in clinical trial design
  • Computational methods for drug design
  • Integration of omics data in drug discovery
  • Ethics of AI in drug development
  • Case studies of successful AI drug discoveries
  • AI for biomarker identification in drug response
  • Big data analytics in pharmaceutical research
  • AI in personalized medicine approaches
  • Challenges in AI for drug discovery
  • Collaborative platforms for drug discovery
  • Regulatory considerations for AI in pharmaceuticals
  • Impact of AI on drug development timelines
  • AI-enhanced virtual screening techniques
  • Future directions in AI for drug discovery
  • Interdisciplinary approaches to drug discovery

Evaluation

Submissions will be evaluated based on applicability, innovation, and research contribution. Accepted papers will be presented and considered for publication in relevant journals and proceedings.

Registration

Complete your registration to participate in discussions that bridge academia and industry, and gain exposure to practical insights.

Publication

Selected papers will be considered for publication platforms that support academic and industry collaboration.

Conference Alert

Due to heightened regional tensions and travel risks, the conference may be conducted in virtual-only mode. Updates regarding participation format will be communicated in advance.